Basit öğe kaydını göster

dc.contributor.authorBuyukcayir, I
dc.contributor.authorKesim, SN
dc.contributor.authorCelik, M
dc.date.accessioned2021-03-03T19:36:52Z
dc.date.available2021-03-03T19:36:52Z
dc.date.issued1997
dc.identifier.citationKesim S., Buyukcayir I., Celik M., "Interferon alpha-2A therapy for keloids", EUROPEAN JOURNAL OF PLASTIC SURGERY, cilt.20, sa.5, ss.282-283, 1997
dc.identifier.issn0930-343X
dc.identifier.othervv_1032021
dc.identifier.otherav_5580dfb8-9201-4b83-bc19-2c5149124959
dc.identifier.urihttp://hdl.handle.net/20.500.12627/60425
dc.identifier.urihttps://doi.org/10.1007/bf01159503
dc.description.abstractKeloid is a frustrating condition both for patient and sur eon. In spite of the availability of many therapeutic modalities such as steroids, radiotherapy, vitamin E, penicillamine and colchicine in some cases keloid management can be unsatisfactory. A 16-year-old boy who was burned in an automobile accident, sustained keloids on the anterior and posterior chest, right face, and left arm. The extensive scarring of the right arm caused him to lose function. Interferon alpha-2a was used for treatment and most of the lesions returned to baseline levers. At IS months follow-up he continued to be symptom-free with good function.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectCerrahi Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCERRAHİ
dc.titleInterferon alpha-2A therapy for keloids
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF PLASTIC SURGERY
dc.contributor.department, ,
dc.identifier.volume20
dc.identifier.issue5
dc.identifier.startpage282
dc.identifier.endpage283
dc.contributor.firstauthorID119296


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster